explanation Clinicians often wonder to what extent the results of studies in patients with depression and anxiety can be generalised to their own routine clinical practice.
There is, however, a remarkable lack of data on the characteristics of ‘real world’ patients and on the results of evidence-based treatments in ‘real world’ clinical practice. Routine outcome monitoring (rom) can provide these data.
We present results from the ggz Rivierduinen/lumc rom-project. We analysed data from a sample of 3798 ‘real-world’ outpatients with a depressive, anxiety or somatoform disorder. In this symposium we will discuss the limitedness of single-questionnaire versions of rom and present data on the clinical characteristics of ‘real world’ outpatients, on the generalisability of the results from trials of pharmacotherapy and psychotherapy to ‘real world’ practice, and on the adherence to guidelines in clinical practice.
aim After the session participants will have acquired insight in the type and relevance of data which can be extracted from rom and will be better able to assess and discuss the relevance of publications on patient characteristics, treatment outcome and guideline adherence for their ‘real world’ practice.